诱导缓解期早期疗效评估在中间核型急性髓系白血病的预后价值
摘要
细胞遗传学中间核型组的急性髓系白血病（AML）约占AML患者的半数以上，为一组异质性的疾病，需要进一步寻找预后因素以指导个体化治治疗。我们在中间核型AML诱导缓解治疗期间进行早期疗效评估，检测不同时点残留白血病细胞比例的预后价值，现报道如下。
参考文献9
-
1Kern W, Haferlach T, Schoch C, et al. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial [J]. Blood, 2003; 101:64-70.
-
2Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendation of the International Working Group for Diagnosis, Standardization of response criteria, treatment outcomes, an Reporting startdards for therapeutic trials in acute myeloid leukemia [J].J Clin Oncol, 2003; 21:4642-4649.
-
3Avivi I, Rowe JM. Prognostic factors in acute myeloid leukemia [J]. Curt Opin Hematol, 2004; 12:62-67.
-
4Grosicki S, Holowiecki J, Giebel S, et al. The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; The results of muhicenter, prospective Polish Adult Leukemia Group Study [J]. Am J Hematol, 2011; 86:437-439.
-
5Xiao Z, Xue H, Li R, et al. The prognostic significance of leukemic cells clearance kinetics evaluation during, the initial course of induction therapy with HAD 0aomoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia [J].Am J Hematol, 2008; 83: 203-205.
-
6Haferlach T, Kern W, Schoch C, et al. A new prognostic score for patients with acute myeloid leukemia based on cytogenetics and early blast clearance in trials of the German AML Cooperative Group [J]. Haematologica, 2004; 89(4):408-418.
-
7Heil G, Krauter J, Raghavachar A, et al. Risk-adapted induction and consolidation therapy in adults with de novo AML aged ≤60 years: results of a prospective multicenter trial [J]. Ann Hematol, 2004; 83:336-344.
-
8Mrzek K, Marucci G, Paschka P, et al. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification [J] ? Blood, 2007; 109: 431-448.
-
9Grimwade D, Vyasb P , Freeman S, et al. Current Assessment of minimal residual disease in acute myeloid leukemia [J].Opinion in Oncology, 2010; 22:656-663.
-
1徐珺,袁国林,吕婷婷,田小龙,黄莹.化疗联合树突状细胞回输治疗急性髓细胞白血病的疗效观察[J].山东医药,2014,54(5):60-62. 被引量：2
-
2江岷,曹履先.环磷酰胺、全身照射和肋骨照射预处理的自体骨髓移植治疗急性白血病[J].山西白血病,1992,1(4):222-222.
-
3汪月增.慢性粒细胞白血病患者骨髓移植后用PCR技术检测残留白血病细胞的临床意义[J].中华血液学杂志,1994,15(8):443-445. 被引量：1
-
4Hughes TP,Goldman JM,王波.慢性粒细胞白血病骨髓移植后残留白血病细胞的生物学重要性:聚合酶链反应是否有帮助?[J].国外医学（输血及血液学分册）,1991,14(5):302-304.
-
5Mart.,AC,阎影.在转移标志基因的白血病大鼠中检测残留白血病细胞...[J].中华肿瘤杂志,1992,14(6):414-417.
-
6伏爽,杨耀明,程康,郭乃榄,王德炳.PCR法检测急性淋巴细胞性白血病患者骨髓移植后残留白血病细胞[J].北京医科大学学报,1998,30(4):369-369.
-
7马月霞,宋增璇,何一心,姜学英,王淑萍,褚建新.残留白血病细胞抗药再生长的实验研究[J].中华血液学杂志,1997,18(5):231-233. 被引量：4
-
8杨晓燕,吕韶敏,何利红,王陵,岳晨莉.甲地孕酮辅助化治治疗老年肺癌36例[J].陕西医学杂志,2011,40(12):1674-1675.
-
9马琦.新辅助化疗治疗晚期卵巢癌疗效分析[J].中国实用医药,2009,4(26):86-87. 被引量：3
-
10薛华,李睿,张莉,杨栋林,李洪强,于明华,郝玉书,肖志坚.急性髓系白血病诱导缓解治疗期残留白血病细胞比例的预后价值[J].中华血液学杂志,2007,28(5):341-343. 被引量：3
